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Edited by Christian GriesingerAbstract We have examined whether the long third intracellu-
lar loop (i3) of the muscarinic acetylcholine receptor M2 subtype
has a rigid structure. Circular dichroism (CD) and nuclear mag-
netic resonance spectra of M2i3 expressed in and puriﬁed from
Escherichia coli indicated that M2i3 consists mostly of random
coil. In addition, the diﬀerential CD spectrum between the M2
and M2Di3 receptors, the latter of which lacks most of i3 except
N- and C-terminal ends, gave no indication of secondary struc-
ture. These results suggest that the central part of i3 of the
M2 receptor has a ﬂexible structure.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Secondary structure1. Introduction
The muscarinic acetylcholine receptor belongs to the super-
family of G protein-coupled receptors (GPCRs) and plays piv-
otal roles in signal transduction. It consists of ﬁve genetically
deﬁned subtypes, M1–M5. One of the structural features of
muscarinic receptors is that each subtype contains a long third
intracellular loop (i3) of 160–240 residues.
Studies based largely on mutagenesis have shown that the
N- and C-terminal portions of i3 play a key role in the speci-
ﬁcity of the coupling of muscarinic receptors to G proteins
[1]. On the other hand, most of the central part of i3 can be
deleted without impairing the ability of the M2 receptor to
couple with G proteins [2], indicating that only the N- and
C-terminal portions of i3 are required for the interaction.
Consistently, most GPCRs have a short i3 and lack its long
central part. On the other hand, dopamine D2–4, adrenergic
a2A–2C, and 5-hydroxytryptamine1A receptors, like muscarinic
receptors, possess a long i3 with more than 100 residues. The
question is raised if these long i3 loops have a common phys-
iological function and similar tertiary structure, although their
sequences are not similar.Abbreviations: CD, circular dichroism; GPCR, G protein-coupled
receptor; GST, glutathione S-transferase; i3, third intracellular loop;
NMR, nuclear magnetic resonance; SDS–PAGE, sodium dodecyl
sulfate–polyacrylamide gel electrophoresis; TM, transmembrane
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of the sites for agonist- and/or second messenger-dependent
phosphorylation [3–5]. For example, the M2 receptor under-
goes agonist-dependent phosphorylation in the i3 by GPCR
kinase 2 followed by desensitization of the receptor [6,7].
The long i3 is also involved in protein–protein interactions.
Regulator of G protein signaling 2 and Gbc are reported to
bind directly to the i3 of M1 and M3 receptors, respectively,
attenuating the receptor activity [8,9].
To the best of our knowledge, however, it has not been re-
ported whether the long i3 of any GPCRs has a physiologically
signiﬁcant tertiary structure. In the present study, we employed
circular dichroism (CD) and nuclear magnetic resonance
(NMR) to elucidate the structure of M2i3 and found it to be
random coil nature.2. Materials and methods
DNA techniques. The cDNA predicted to encode the whole M2i3
(His208–Thr388) was ampliﬁed by polymerase chain reaction, where
a sequence encoding 6· His tag (H) was added at the downstream,
and EcoRI and NotI sites were introduced to the 5 0- and 3 0-ends,
respectively. The resultant DNA was digested and ligated to pGEX-
6P-3 (Amersham Biosciences, Little Chalfont, UK) to construct
pGEXM2i3H, which produces glutathione S-transferase (GST)-
M2i3H (Fig. 1A and B). DNA sequence was conﬁrmed with the Ap-
plied Biosystems 3100-Avant sequencer (Foster City, CA).
Puriﬁcation of GST–M2i3H, M2i3H, and GST. Escherichia coli
BLR(DE3) transfected with pGEXM2i3H were grown aerobically at
37 C for 12 h in LB medium (2 L) containing 0.1 mg/mL ampicillin.
After mixed with 0.2 mg/mL ampicillin and 0.2 mM isopropyl-1-thio-
b-D-galactoside, the cells were further cultivated at 25 C for 12 h.
The cells were harvested and resuspended in phosphate buﬀered saline
(PBS)(50 mL) containing 50 lg/mL lysozyme, 1 lM pepstatin A,
0.28 lM E-64, 0.2 mM benzamidine, 10 lM leupeptin, 0.2% (w/v) Tri-
ton X-100, 0.5 mM phenylmethanesulfonyl ﬂuoride, and 0.02% (w/v)
protamine. The cells were disrupted by sonication (4 cycles of 15 s
on and 45 s oﬀ at level 4) with a Tomy UD-200 ultrasonic disruptor
(Tokyo), and subjected to centrifugation. Column chromatography
was performed with the A¨KTA system (Amersham Biosciences) at
room temperature. The supernatant was loaded onto Glutathione Se-
pharose 4B (5 mL) and washed with 50 mM Tris–Cl, pH 8.0, contain-
ing 150 mM NaCl (50 mL). The column was detached from the system
and incubated at 5 C for 4 h after applying PreScission Protease (80
units). After incubation, it was reattached and washed with the buﬀer
(15 mL). The eluted M2i3H was then loaded onto HiTrap Chelating
Sepharose (1 mL), washed with PBS containing 10 mM imidazole
(10 mL), and eluted with PBS containing 500 mM imidazole
(5.5 mL). The imidazole was removed with Superdex 200 10/300 GL
(24 mL) preequilibrated with PBS. The fractions containing puriﬁed
M2i3H were concentrated (6 mLﬁ 200 lL) with a Centricon YM-10blished by Elsevier B.V. All rights reserved.
Fig. 1. Schematic diagrams of the M2 receptors and the expression
construct. (A) A putative topology of theM2 receptor. (B) Construction
of GST–M2i3H. The sequence encoded by the multi-cloning site of
pGEX-6P-3, Leu-Gly-Ser-Pro-Asn-Ser, was inserted between the Pre-
Scission Protease site (Leu-Glu-Val-Leu-Phe-Gln-Gly-Pro) andM2i3H.
Digestion with the protease leaves Gly-Pro. (C) The M2 and M2Di3
receptors.Asn residues (2, 3, 6, and9),whichmayundergoglycosylation,
were replaced by Asp to avoid heterogeneity due to attachment of
oligosaccharides. The central part of i3 (Pro233–Ser380), which contains
all the phosphorylation sites, was deleted in M2Di3.
Fig. 2. Puriﬁcation of the proteins. The puriﬁed GST–M2i3H (A, lane
2), GST (A, lane 3), and M2i3H (B, lane 2): 0.5 lg (A) and 2.6 lg (B) of
proteins were subjected to SDS–PAGE and stained with Coomassie
brilliant blue R-250. Calculated mass of GST–M2i3H is 47649.
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lected from Glutathione Sepharose 4B with 50 mM Tris–Cl, pH 8.0,
containing 10 mM reduced glutathione after elution of M2i3H. The
cleavage step was omitted to prepare GST–M2i3H. The N-terminal se-
quence of the puriﬁed M2i3H was conﬁrmed with Shimadzu PPSQ-21
(Kyoto) and Applied Biosystems 476A protein sequencers. Protein
concentrations were determined using a BCA protein assay kit (Pierce,
Rockford, IL) or by UV spectrometry using extinction coeﬃcients cal-
culated by the program ProtParam [10].
Expression and puriﬁcation of the M2 and M2Di3 receptors. Two re-
combinant baculoviruses were prepared, one with cDNA for the M2
receptor and the other with cDNA for the M2Di3 receptor [11]
(Fig. 1C). The receptors were expressed using the recombinant Sf9 cells
as described [2]. Both receptors were puriﬁed by 3-(2 0-aminobenzhyd-
ryloxy)tropane-based aﬃnity chromatography, and the puriﬁed recep-
tors were eluted as quinuclidinyl benzilate-bound form from a
hydroxyapatite column, as described [2,12].
CD spectrum measurements. CD spectra were taken at 30 C in a
quartz cell with a 1-mm light path with a Jasco J-720 CD spectro-
photometer (Tokyo). GST–M2i3H, GST, and M2i3H were adjusted
to 0.1 mg/mL with PBS; M2 and M2Di3 were adjusted to 0.1 mg/mL
with PBS containing 0.2% (w/v) decylmaltoside and 0.05% (w/v)
digitonin. CD intensities (mdeg) were recorded between 200
and 260 nm in steps of 0.05 nm, and converted to molar ellipticity
h values: deg cm2 dmol1 ¼ mdeg 103ðdegÞ=f0:1 mg=mL=ðmolecular
weightÞðmol=LÞ  1=100ðdmol=cm3Þ  0:1 cmg. The scan was repeated 2–3
times and averaged. To calculate the diﬀerential CD spectra between
GST–M2i3H and GST and between M2 and M2Di3, the respective h
values for the latter proteins were subtracted from those for the for-
mer at all wavelength points. The a-helix content (%) was calculated
using the equation, 100 · ([h]222/n) · 1/{40000 · (1  2.5/n)}, where
n is the number of residues in the peptide [13].NMR spectroscopy. Proton NMR spectra were acquired using Bru-
ker Avance 800 MHz spectrometer equipped with cryoprobe (Bruker
BioSpin, Karlsruhe, Germany). M2i3H (82 lM) in 300 ll PBS contain-
ing 5% D2O (v/v) was used for the measurements. One-dimensional
experiments were performed with water suppression using WATER-
GATE pulse sequence with pulse ﬁeld gradients [14]. Data were col-
lected at 298 K, and were analyzed using XWINNMR 3.5 (Bruker).3. Results
Puriﬁcation of GST–M2i3H, M2i3H, and GST. We con-
structed GST–M2i3H (Fig. 1B) to allow puriﬁcation by both
glutathione- and metal ion-based aﬃnity chromatography.
M2i3H was isolated from GST–M2i3H by cleavage of the Pre-
Scission Protease site which resides between GST and M2i3H.
These proteins were puriﬁed to homogeneity (Fig. 2). The
band of M2i3H (Fig. 2B, lane 2; calculated mass, 21236) ap-
peared above the band of GST (Fig. 2A, lane 3; calculated
mass, 26431). The N-terminal sequencing demonstrated that
the isolated band shown in lane 2 of Fig. 2B possessed the stub
sequence of the PreScission Protease site, followed by 6 amino
acids encoded by the vector and the N-terminal sequence of
M2i3H (data not shown; see legend of Fig. 1B). Thus, the band
was conﬁrmed to be M2i3H. There are many basic residues in
N- and C-terminal portions of M2i3H, and the isoelectric point
(pI) of M2i3H was estimated to be 9.34 from the primary struc-
ture [10]. On the other hand, the pI value of GST was esti-
mated to be 5.73. The basic nature of M2i3H may have
caused slower migration compared with GST and marker
proteins.
Secondary structures of GST–M2i3H, GST, and M2i3H.
GST–M2i3H and GST gave CD spectra typical of proteins
containing secondary structures (Fig. 3A). Contrary to the
CD spectra of the two proteins, the diﬀerential CD spectrum,
which should represent the spectrum for the M2i3H part of
GST–M2i3H, was close to that observed for random coil pep-
tides. The helix contents of GST–M2i3H, GST, and M2i3H
were calculated to be 15.7%, 23.4%, and 7.0%, respectively.
For isolated M2i3H, the CD spectrum (Fig. 3B) was similar
to the diﬀerential one (Fig. 3A), supporting the idea that M2i3
has little secondary structure. The helix content of the puriﬁed
M2i3H was calculated to be 13.3%. The possibility that a small
Fig. 3. CD spectra of the proteins. (A) GST–M2i3H, GST, and the
diﬀerence. (B) The isolated M2i3H. (C) M2, M2Di3, and the diﬀerence.
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pressed pattern of the spectrum around 208–222 nm.
The random coil nature of M2i3H was further conﬁrmed by
1D NMR (Fig. 4). The resonances attributed to methyl groups
of amino acid residues seem not to be found in the range 0.0–
0.5 but rather in the range over 0.7 ppm (Fig. 4C). Many sig-
nals were found to accumulate around 8.0 ppm (Fig. 4B),
which corresponds to the region of amide proton. These resultssuggest that the puriﬁed M2i3H is not likely to have an ordered
structure.
CD analysis of M2 and M2Di3. The structure of the isolated
peptide produced in E. coli may not necessarily represent the
structure of the same sequence in the intact receptor: the con-
straints imposed by covalent attachment to the transmembrane
(TM) regions as well as the interaction with other cytoplasmic
region(s) might result in stabilization of a certain conforma-
tional state of i3. To examine this possibility, we prepared an
M2 receptor mutant lacking most of i3 (M2Di3), which is
known to show essentially the same pharmacological proper-
ties as the wild-type M2 receptors [2,11] (Fig. 1C). Both M2
and M2Di3 receptors were puriﬁed to homogeneity as assessed
by gel chromatography (Superdex 200 10/300 GL) and sodium
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–
PAGE; data not shown), as described previously [2,11,12].
Both M2 and M2Di3 receptors exhibited the spectra typical
of proteins containing secondary structures (Fig. 3C): the helix
contents of M2 and M2Di3 were calculated to be 46.6% and
90.7%, respectively. This is consistent with the widely accepted
notion that GPCRs are composed of 7 TM a-helices. In fact,
analysis of the crystal structure of bovine rhodopsin (PDB
ID, 1F88) provided the following proportions of secondary
structures (%): b-strand, 3.6; a-helix, 58.9; 310 helix, 2.7; oth-
ers, 34.9 [15]. The diﬀerential CD spectrum corresponding to
i3 in the receptor, however, showed no signs of secondary
structure. The estimation of the helix content in i3 (Pro233–
Ser380) gave a negative value, suggesting that no a-helix was
present in the central part of i3.4. Discussion
In the present study, we have shown that M2i3 has little sec-
ondary structure: the helix content in M2i3H (His208–Thr388)
puriﬁed from E. coli and in the central part of i3 (Pro233–
Ser380) in the receptor was estimated to be 13.3% and 0%,
respectively, from the mean residue ellipticity values at
222 nm ([h]222/n).
In other studies, the N- and C-terminal portions of i3 in
muscarinic receptors and other GPCRs have been shown to
form a-helices which are extensions of TM5 and TM6, respec-
tively, based largely on ﬁndings that a thorough mutagenesis
of relevant residues showed the periodicity in tolerance to
the substitutions or the lack of tolerance by disrupting putative
a-helix by substitution with proline [1,16]. We subjected the
M2i3 sequence to prediction of the secondary structure using
the two programs, Porter [17] and PSIpred [18], and found that
the central part of i3 was predicted to be mainly coil by either
program, a-helix and/or b-strand to lie near or adjacent to the
N- and C-terminal regions, and the helix content to be 13.3%
and 8.8%, respectively, by the two programs. These predictions
are consistent with our present ﬁnding that there is a small
amount of secondary structure in the full-length of isolated
M2i3 but no secondary structure in the central part of i3 in
the M2 receptor.
The structure determined for the isolated i3may not represent
the actual structure in the receptor in vivo, as i3 may be inﬂu-
enced by other intracellular loop(s) and/or the C-terminal tail.
This has been shownnot to be the case, however, for the intracel-
lular loops of rhodopsin as follows. NMR analyses of the syn-
thetic i1, i2, and i3 peptides of rhodopsin have revealed that
Fig. 4. 1H 1D NMR of the isolated M2i3H. The complete (A), expansion of the amide proton (B), and high ﬁeld (C) regions.
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or b-turn and that both ends of each peptide are close together,
thereby positioning the termini appropriately for connection of
adjacent TM helices, as would occur in the intact receptor, even
though TM helices were absent in these peptides [19,20]. The X-
ray crystallographic analysis of rhodopsin, in which most of the
residues of the loops were identiﬁed, veriﬁed that these cytoplas-
mic loops have an ordered structure rather than a random one
[15]. In the present report also, essentially the same results were
obtained for isolated i3 and the i3 in M2 receptor, conﬁrming
that the central part of M2i3 does not have secondary structure,
and that other intracellular loops and/or the C-terminal end
probably have little, if any, inﬂuence on its structure. The possi-
bility remains, however, that i3 may form a deﬁnite structure
when it binds cytosolic protein(s). It should be noted in this con-
text that some proteins, which can constitute supramolecular
complexes, form a cooperatively folded structure only after they
meet the binding partner, though the isolated domains are
intrinsically disordered [21].
In conclusion, the present results suggest that the central
part of the third intracellular loop of the M2 receptor (M2i3)
does not have secondary structure, and most probably has a
ﬂexible structure, though its N- and/or C-terminal regions
may form a-helices. Several questions remain to be answered
in the future: (1) Could this conclusion be generalized to the
long i3 of other GPCRs? (2) Is the ﬂexibility required for the
function of the long i3? (3) Do C-terminal tails of many
GPCRs, which have functions similar to those of the long i3,
have a ﬂexible structure?
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